180 related articles for article (PubMed ID: 11733868)
1. Indomethacin does not affect endogenous glucose production in type 2 diabetes mellitus.
Pereira Arias AM; Bisschop PH; Ackermans MT; Endert E; Romijn JA; Sauerwein HP
Horm Metab Res; 2001 Nov; 33(11):659-63. PubMed ID: 11733868
[TBL] [Abstract][Full Text] [Related]
2. Beta cell response to oral glimepiride administration during and following a hyperglycaemic clamp in NIDDM patients.
van der Wal PS; Draeger KE; van Iperen AM; Martini C; Aarsen M; Heine RJ
Diabet Med; 1997 Jul; 14(7):556-63. PubMed ID: 9223393
[TBL] [Abstract][Full Text] [Related]
3. Type 2 diabetic patients have increased gluconeogenic efficiency to substrate availability, but intact autoregulation of endogenous glucose production.
Toft I; Jenssen T
Scand J Clin Lab Invest; 2005; 65(4):307-20. PubMed ID: 16076686
[TBL] [Abstract][Full Text] [Related]
4. Defective amplification of the late phase insulin response to glucose by GIP in obese Type II diabetic patients.
Vilsbøll T; Krarup T; Madsbad S; Holst JJ
Diabetologia; 2002 Aug; 45(8):1111-9. PubMed ID: 12189441
[TBL] [Abstract][Full Text] [Related]
5. Role of glucagon, catecholamines, and growth hormone in human glucose counterregulation. Effects of somatostatin and combined alpha- and beta-adrenergic blockade on plasma glucose recovery and glucose flux rates after insulin-induced hypoglycemia.
Rizza RA; Cryer PE; Gerich JE
J Clin Invest; 1979 Jul; 64(1):62-71. PubMed ID: 36413
[TBL] [Abstract][Full Text] [Related]
6. Prandial regulation of ghrelin secretion in humans: does glucagon contribute to the preprandial increase in circulating ghrelin?
Soule S; Pemberton C; Hunt P; Cole D; Raudsepp S; Inder W
Clin Endocrinol (Oxf); 2005 Oct; 63(4):412-7. PubMed ID: 16181233
[TBL] [Abstract][Full Text] [Related]
7. Both fasting glucose production and disappearance are abnormal in people with "mild" and "severe" type 2 diabetes.
Basu R; Schwenk WF; Rizza RA
Am J Physiol Endocrinol Metab; 2004 Jul; 287(1):E55-62. PubMed ID: 14982753
[TBL] [Abstract][Full Text] [Related]
8. Comparison of the effects of pioglitazone and metformin on hepatic and extra-hepatic insulin action in people with type 2 diabetes.
Basu R; Shah P; Basu A; Norby B; Dicke B; Chandramouli V; Cohen O; Landau BR; Rizza RA
Diabetes; 2008 Jan; 57(1):24-31. PubMed ID: 17914032
[TBL] [Abstract][Full Text] [Related]
9. Effects of glucocorticoids on hepatic sensitivity to insulin and glucagon in man.
Dirlewanger M; Schneiter PH; Paquot N; Jequier E; Rey V; Tappy L
Clin Nutr; 2000 Feb; 19(1):29-34. PubMed ID: 10700531
[TBL] [Abstract][Full Text] [Related]
10. Islet hormonal regulation of glucose turnover during exercise in type 1 diabetes.
Shilo S; Sotsky M; Shamoon H
J Clin Endocrinol Metab; 1990 Jan; 70(1):162-72. PubMed ID: 1967178
[TBL] [Abstract][Full Text] [Related]
11. Type I diabetes mellitus does not alter initial splanchnic glucose extraction or hepatic UDP-glucose flux during enteral glucose administration.
Vella A; Shah P; Basu R; Basu A; Camilleri M; Schwenk WF; Rizza RA
Diabetologia; 2001 Jun; 44(6):729-37. PubMed ID: 11440366
[TBL] [Abstract][Full Text] [Related]
12. Indomethacin decreases insulin secretion in patients with type 2 diabetes mellitus.
Pereira Arias AM; Romijn JA; Corssmit EP; Ackermans MT; Nijpels G; Endert E; Sauerwein HP
Metabolism; 2000 Jul; 49(7):839-44. PubMed ID: 10909992
[TBL] [Abstract][Full Text] [Related]
13. Pathogenesis of the dawn phenomenon in patients with insulin-dependent diabetes mellitus. Accelerated glucose production and impaired glucose utilization due to nocturnal surges in growth hormone secretion.
Campbell PJ; Bolli GB; Cryer PE; Gerich JE
N Engl J Med; 1985 Jun; 312(23):1473-9. PubMed ID: 2859524
[TBL] [Abstract][Full Text] [Related]
14. Advantageous metabolic effects of pulsatile insulin delivery in noninsulin-dependent diabetic patients.
Paolisso G; Sgambato S; Gentile S; Memoli P; Giugliano D; Varricchio M; D'Onofrio F
J Clin Endocrinol Metab; 1988 Nov; 67(5):1005-10. PubMed ID: 3053747
[TBL] [Abstract][Full Text] [Related]
15. Aminophylline stimulates insulin secretion in patients with type 2 diabetes mellitus.
Arias AM; Bisschop PH; Ackermans MT; Nijpels G; Endert E; Romijn JA; Sauerwein HP
Metabolism; 2001 Sep; 50(9):1030-5. PubMed ID: 11555834
[TBL] [Abstract][Full Text] [Related]
16. Effect of overnight restoration of euglycemia on glucose effectiveness in type 2 diabetes mellitus.
Basu R; Basu A; Nielsen M; Shah P; Rizza RA
J Clin Endocrinol Metab; 1999 Jul; 84(7):2314-9. PubMed ID: 10404795
[TBL] [Abstract][Full Text] [Related]
17. Glucose flux in controlled hyperglycaemia before and after oral glucose ingestion in men with mild type 2 diabetes.
Rigalleau V; Beauvieux MC; Gallis JL; Gin H; Schneiter P; Tappy L
Diabetes Metab; 2010 Jun; 36(3):234-9. PubMed ID: 20303815
[TBL] [Abstract][Full Text] [Related]
18. Postprandial glycaemic effects of a long-acting somatostatin analogue (octreotide) in non-insulin dependent diabetes mellitus.
Williams G; Füessl HS; Burrin JM; Chilvers E; Bloom SR
Horm Metab Res; 1988 Mar; 20(3):168-70. PubMed ID: 2898427
[TBL] [Abstract][Full Text] [Related]
19. Indomethacin stimulates glucose production in adults with uncomplicated falciparum malaria.
Dekker E; Romijn JA; Huynh ; Ackermans MT; Endert E; Kager PA; Thuy LT; Sauerwein HP
Metabolism; 1998 Feb; 47(2):217-22. PubMed ID: 9472974
[TBL] [Abstract][Full Text] [Related]
20. Time of peritoneal cavity exposure influences postoperative glucose production.
Schricker T; Carli F; Schreiber M; Laftermann R; Georgieff M
Can J Anaesth; 1999 Apr; 46(4):352-8. PubMed ID: 10232719
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
